BioArctic AB (publ) Profit Margin

BioArctic AB (publ) posts a profit margin of 10.53% as of June 2026. That compares with 57.37% in the prior-year period — down 81.6% year over year. That is above the Healthcare sector average of 9.71%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, BioArctic AB (publ)'s profit margin was 57.37%. The latest reading is 10.53% — a 81.6% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 9.71% is typical. BioArctic AB (publ)'s 10.53% is higher that level. That is roughly 8.5% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

BioArctic AB (publ)'s profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 10.53% as of June 2026; use YoY and peer views to separate noise from signal.

Context for BRCTF's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 9.71%), and (3) consistency with growth and profitability. This page covers the first two; BioArctic AB (publ)'s other metric pages and overview cover the third.